Immediate Impact

1 by Nobel laureates 87 standout
Sub-graph 1 of 21

Citing Papers

mRNA-based therapeutics: looking beyond COVID-19 vaccines
2024 StandoutNobel
Humoral Innate Immunity and Acute-Phase Proteins
2023 Standout
2 intermediate papers

Works of Javier Belda being referenced

Evaluating the efficacy of dexamethasone in the treatment of patients with persistent acute respiratory distress syndrome: study protocol for a randomized controlled trial
2016
An Early PEEP/F i O 2 Trial Identifies Different Degrees of Lung Injury in Patients with Acute Respiratory Distress Syndrome
2007

Author Peers

Author Last Decade Papers Cites
Javier Belda 633 267 309 380 331 32 1.2k
Thomas Godet 541 330 416 413 428 44 1.3k
Alessandro Putzu 288 142 241 393 288 46 1.1k
Joseph E. Arrowsmith 395 150 295 565 515 50 1.3k
Maurizio Chiaranda 937 395 388 148 211 35 1.3k
Lars Heslet 302 179 186 328 431 41 1.3k
Adebola Adesanya 638 148 261 252 206 18 1.0k
Maurizio Passariello 603 228 370 105 277 28 1.2k
Heinrich V. Groesdonk 294 145 233 292 360 61 941
Scott R. Schulman 270 256 163 255 374 43 1.1k
Evgeny Fominskiy 308 135 280 365 429 45 1.3k

All Works

Loading papers...

Rankless by CCL
2026